The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody

被引:5
|
作者
Li, Guanlin [1 ]
Qu, Ye [1 ]
Cai, Chenguang [1 ]
Kong, Yirong [1 ]
Liu, Shuling [1 ]
Zhang, Jun [1 ]
Zhao, Jian [1 ]
Fu, Ling [1 ]
Xu, Junjie [1 ]
Chen, Wei [1 ]
机构
[1] Beijing Inst Microbiol & Epidemiol, Dept Appl Mol Biol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
Anthrax protective antigen; Capillary morphogenesis protein 2; Monoclonal antibody; Epitope; CAPILLARY MORPHOGENESIS PROTEIN-2; CRYSTAL-STRUCTURE; BINDING;
D O I
10.1016/j.bbrc.2009.05.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high affinity binding of thearithrax protective antigen (PA) to one of its receptors, capillary morphogenesis protein 2 (CMG2), is essential for the intoxication process of anthrax toxin. To acquire novel research tools to Study the PA-CMG2 interaction, we generated several anti-CMG2 monoclonal antibodies (MAbs). We demonstrated that one of the MAbs, 4B5, Could inhibit PA-CMG2 binding and Could also protect the sensitive cells against an anthrax lethal toxin challenge. We identified the epitope recognized by 4B5 and confirmed that the key residues of the epitope were the residues (YI)-Y-119-LK125 of CMG2. Based on our results, we propose that 4B5 binds to the E122 pocket of CMG2 and interrupts the interaction between the pocket and the PA 2 beta 3-2 beta 4 loop. TO our knowledge, this is the first report to illustrate that an anti-CMG2 antibody Could inhibit the PA-CMG2 interaction and therefore interfere with the intoxication of anthrax toxin. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:591 / 595
页数:5
相关论文
共 50 条
  • [31] Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
    Deng, Rong
    Loyet, Kelly M.
    Lien, Samantha
    Iyer, Suhasini
    DeForge, Laura E.
    Theil, Frank-Peter
    Lowman, Henry B.
    Fielder, Paul J.
    Prabhu, Saileta
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (04) : 600 - 605
  • [32] A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Sunakawa, Yu
    Shimada, Ken
    Ishida, Hiroo
    Hasegawa, Kosei
    Fujiwara, Keiichi
    Kodaira, Makoto
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Matsuda, Minami
    Takeuchi, Yutaka
    Katsumata, Noriyuki
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (02) : 332 - 340
  • [33] A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors
    Yasutsuna Sasaki
    Keisuke Miwa
    Keishi Yamashita
    Yu Sunakawa
    Ken Shimada
    Hiroo Ishida
    Kosei Hasegawa
    Keiichi Fujiwara
    Makoto Kodaira
    Yasuhiro Fujiwara
    Masayuki Namiki
    Minami Matsuda
    Yutaka Takeuchi
    Noriyuki Katsumata
    Investigational New Drugs, 2015, 33 : 332 - 340
  • [34] A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas
    Faillot, T
    Magdelenat, H
    Mady, E
    Stasiecki, P
    Fohanno, D
    Gropp, P
    Poisson, M
    Delattre, JY
    NEUROSURGERY, 1996, 39 (03) : 478 - 483
  • [35] INHIBITION OF THE T-CELL RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION BY MICROINJECTION OF ANTI-LCK MONOCLONAL-ANTIBODY INTO T-CELLS
    NAKAMURA, K
    KOGA, Y
    YOSHIDA, H
    TANAKA, K
    SASAKI, M
    KIMURA, G
    NOMOTO, K
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1224 (03): : 495 - 505
  • [36] Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain
    Kilic, Gamze
    Demirkan, Elif
    Yucel, Fatima
    MOLECULAR BIOTECHNOLOGY, 2024, 67 (4) : 1556 - 1564
  • [37] Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors
    Wang, Chong
    He, Xiaohui
    Zhou, Bo
    Li, Jing
    Li, Bohua
    Qian, Weizhu
    Hou, Sheng
    Wang, Hao
    Shi, Yuankai
    Guo, Yajun
    MABS, 2011, 3 (01) : 67 - 75
  • [38] Ramucirumab (IMC-1121B): Monoclonal Antibody Inhibition of Vascular Endothelial Growth Factor Receptor-2
    Jennifer Spratlin
    Current Oncology Reports, 2011, 13 : 97 - 102
  • [39] Computational investigation of the interaction mechanism between the estrogen related receptor α and its agonists
    Li, Fuxing
    Sun, Xianqiang
    Cai, Yingchun
    Fan, Defang
    Li, Weihua
    Tang, Yun
    Liu, Guixia
    RSC ADVANCES, 2016, 6 (96): : 94119 - 94127
  • [40] Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells
    Zhang, Youcheng
    Zhang, Yawu
    CANCER INVESTIGATION, 2008, 26 (03) : 230 - 236